Abstract
ABSTRACT Nowadays global inequalities in access to vaccines seem to be a growing problem. Intellectual Property Rights (IPRs) have been playing an important role both in causing and worsening them. Firstly, IPRs have promoted a scheme of each-country/each-company negotiation, which clearly has left many low-income countries almost out of vaccine supplies. Several middle-income countries have had to make tremendous efforts, at the expense of reducing the budget for meeting other social needs, to pay for the vaccines as well. Secondly, the COVAX mechanism, which was precisely designed to ensure the availability of vaccines to the Global South, has been severely weakened under this dominant scheme of negotiation. And thirdly, the provided exceptional mechanisms to increase vaccine availability under the current IPR regime do not work in practice because of the many precise conditions that must be fulfilled under that regime. Since under these circumstances many lives can be prematurely lost, the waiver of vaccine IPRs becomes a morally crucial demand.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
